ZBED10P: A Key Regulator of Cell Division and Cancer (G113763)

Target Name: ZBED10P

NCBI ID: G113763

ZBED10P

ZBED10P: A Key Regulator of Cell Division and Cancer

ZBED10P (C7orf29) is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell division and has been implicated in the development and progression of many diseases, including cancer. In recent years, researchers have been investigating the potential uses of ZBED10P as a drug target or biomarker.

One of the main reasons for the interest in ZBED10P is its role in cell division. In many organisms, cell division is regulated by a complex network of genes that work together to ensure the proper growth and development of cells. ZBED10P is a key component of this network and plays a crucial role in regulating the formation of new cells.

One of the ways that ZBED10P regulates cell division is through the production of microtubules, which are important for the movement of cells and the transport of materials within the cell. Microtubules are made up of a protein called T-tubin, which is complexed with ZBED10P. This complex interaction between T-tubin and ZBED10P allows for the regulation of microtubule dynamics and the proper movement of cells.

In addition to its role in cell division, ZBED10P has also been shown to play a key role in the development and progression of many diseases. For example, ZBED10P has been shown to be involved in the development of cancer, both in humans and in animals. Studies have shown that high levels of ZBED10P are associated with an increased risk of cancer and that inhibiting its activity may be a potential strategy for treating cancer.

Another potential use of ZBED10P as a drug target is its role in the regulation of inflammation. ZBED10P has been shown to play a key role in the production of pro-inflammatory cytokines, which contribute to the inflammatory response that occurs in response to injury or infection. By inhibiting the activity of ZBED10P, researchers may be able to reduce the production of pro-inflammatory cytokines and improve the body's ability to fight off infections and injuries.

In addition to its potential uses as a drug target or biomarker, ZBED10P has also been shown to have potential as a diagnostic tool. For example, studies have shown that ZBED10P is expressed in a variety of tissues and that its levels can be used as a marker for certain types of cancer. In addition, ZBED10P has been shown to be expressed in the brains of individuals with certain genetic mutations, which suggests that it may be a useful biomarker for certain types of brain cancer.

Overall, ZBED10P is a protein that has the potential to be a drug target or biomarker in a variety of diseases. Its role in cell division and its involvement in the development and progression of many diseases make it an attractive target for researchers, while its potential as a diagnostic tool adds to its potential uses. Further research is needed to fully understand the role of ZBED10P in these processes and to develop safe and effective treatments.

Protein Name: Zinc Finger BED-type Containing 10, Pseudogene

The "ZBED10P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZBED10P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets